Li Shu-Jing, Li Ya, Cui Shi-chao, Qi Yao, Zhao Jing-Jing, Liu Xiao-Yan, Xu Ping, Chen Xian-Hua
State Key Laboratory of Medical Neurobiology and Department of Neurobiology,School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shanghai, China.
PLoS One. 2013 Aug 19;8(8):e72220. doi: 10.1371/journal.pone.0072220. eCollection 2013.
Regulator of G protein signaling 4 (RGS4) is a critical modulator of G protein-coupled receptor (GPCR)-mediated signaling and plays important roles in many neural process and diseases. Particularly, drug-induced alteration in RGS4 protein levels is associated with acute and chronic effects of drugs of abuse. However, the precise mechanism underlying the regulation of RGS4 expression is largely unknown. Here, we demonstrated that the expression of RGS4 gene was subject to regulation by alternative splicing of the exon 6. Transformer-2β (Tra2β), an important splicing factor, bound to RGS4 mRNA and increased the relative level of RGS4-1 mRNA isoform by enhancing the inclusion of exon 6. Meanwhile, Tra2β increased the expression of full-length RGS4 protein. In rat brain, Tra2β was co-localized with RGS4 in multiple opioid action-related brain regions. In addition, the acute and chronic morphine treatment induced alteration in the expression level of Tra2β in rat locus coerulus (LC) in parallel to that of RGS4 proteins. It suggests that induction of this splicing factor may contribute to the change of RGS4 level elicited by morphine. Taken together, the results provide the evidence demonstrating the function of Tra2β as a new mediator in opioid-induced signaling pathway via regulating RGS4 expression.
G蛋白信号调节因子4(RGS4)是G蛋白偶联受体(GPCR)介导信号传导的关键调节因子,在许多神经过程和疾病中发挥重要作用。特别是,药物引起的RGS4蛋白水平变化与滥用药物的急性和慢性效应相关。然而,RGS4表达调控的确切机制在很大程度上尚不清楚。在此,我们证明RGS4基因的表达受外显子6可变剪接的调控。重要的剪接因子Transformer-2β(Tra2β)与RGS4 mRNA结合,并通过增强外显子6的包含来增加RGS4-1 mRNA异构体的相对水平。同时,Tra2β增加了全长RGS4蛋白的表达。在大鼠脑中,Tra2β与RGS4在多个阿片类药物作用相关脑区共定位。此外,急性和慢性吗啡处理诱导大鼠蓝斑(LC)中Tra2β表达水平的改变,与RGS4蛋白的改变平行。这表明该剪接因子的诱导可能有助于吗啡引起的RGS4水平变化。综上所述,这些结果提供了证据,证明Tra2β作为一种新的介质,通过调节RGS4表达在阿片类药物诱导的信号通路中发挥作用。